Derek Law

936 total citations
17 papers, 716 citations indexed

About

Derek Law is a scholar working on Infectious Diseases, Epidemiology and Organic Chemistry. According to data from OpenAlex, Derek Law has authored 17 papers receiving a total of 716 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 9 papers in Epidemiology and 4 papers in Organic Chemistry. Recurrent topics in Derek Law's work include Antifungal resistance and susceptibility (16 papers), Fungal Infections and Studies (8 papers) and Infectious Diseases and Mycology (4 papers). Derek Law is often cited by papers focused on Antifungal resistance and susceptibility (16 papers), Fungal Infections and Studies (8 papers) and Infectious Diseases and Mycology (4 papers). Derek Law collaborates with scholars based in United States, United Kingdom and Australia. Derek Law's co-authors include Nathan P. Wiederhold, Michael Birch, Mike Birch, Jason D. Oliver, Nicola Beckmann, Graham E. M. Sibley, Saskia du Pré, Joanne Livermore, A. J. Kennedy and John Rex and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Derek Law

17 papers receiving 710 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Derek Law United States	13	619	497	110	105	98	17	716
Katsura Hata Japan	10	705 1.1×	596 1.2×	90 0.8×	113 1.1×	166 1.7×	17	916
Caroline B. Moore United Kingdom	10	876 1.4×	581 1.2×	168 1.5×	156 1.5×	111 1.1×	12	997
Juan Alejandro Neira Mosquera Ecuador	15	479 0.8×	365 0.7×	152 1.4×	127 1.2×	101 1.0×	37	820
Laurence F. Mirels United States	10	539 0.9×	456 0.9×	62 0.6×	45 0.4×	131 1.3×	11	734
Marcos Olivo United States	16	590 1.0×	495 1.0×	53 0.5×	44 0.4×	53 0.5×	19	624
Ahmed S. Bueid Saudi Arabia	7	484 0.8×	353 0.7×	95 0.9×	110 1.0×	63 0.6×	8	607
D. T. A. Te Dorsthorst Netherlands	11	368 0.6×	259 0.5×	72 0.7×	51 0.5×	65 0.7×	14	471
Montserrat Ortoneda Spain	17	444 0.7×	398 0.8×	134 1.2×	280 2.7×	92 0.9×	21	766
Lea Gregson United Kingdom	16	571 0.9×	463 0.9×	93 0.8×	47 0.4×	68 0.7×	18	771
Henrich A. L. van der Lee Netherlands	8	687 1.1×	477 1.0×	125 1.1×	231 2.2×	83 0.8×	10	821

Countries citing papers authored by Derek Law

Since Specialization

Citations

This map shows the geographic impact of Derek Law's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Derek Law with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Derek Law more than expected).

Fields of papers citing papers by Derek Law

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Derek Law. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Derek Law. The network helps show where Derek Law may publish in the future.

Co-authorship network of co-authors of Derek Law

This figure shows the co-authorship network connecting the top 25 collaborators of Derek Law. A scholar is included among the top collaborators of Derek Law based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Derek Law. Derek Law is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Oliver, Jason D., et al.. (2025). In vitro evaluation of olorofim and antifungal combinations against Aspergillus and Candida species. Journal of Antimicrobial Chemotherapy. 80(11). 3139–3149. 1 indexed citations

Halliday, Catriona, Enoch Tay, Wendy Green, et al.. (2024). In vitro activity of olorofim against 507 filamentous fungi including antifungal drug-resistant strains at a tertiary laboratory in Australia: 2020–2023. Journal of Antimicrobial Chemotherapy. 79(10). 2611–2621. 11 indexed citations

Nunnally, Natalie S., et al.. (2023). In Vitro Activity of the Novel Antifungal Olorofim against Scedosporium and Lomentospora prolificans. Microbiology Spectrum. 11(1). e0278922–e0278922. 12 indexed citations

Buil, Jochem B., Jason D. Oliver, Derek Law, et al.. (2022). Resistance profiling of Aspergillus fumigatus to olorofim indicates absence of intrinsic resistance and unveils the molecular mechanisms of acquired olorofim resistance. Emerging Microbes & Infections. 11(1). 703–714. 34 indexed citations

Nunnally, Natalie S., Eric M. Ransom, Derek Law, et al.. (2021). In Vitro Activity of Novel Antifungal Olorofim against Filamentous Fungi and Comparison to Eight Other Antifungal Agents. Journal of Fungi. 7(5). 378–378. 33 indexed citations

Pré, Saskia du, Mike Birch, Derek Law, et al.. (2020). The Dynamic Influence of Olorofim (F901318) on the Cell Morphology and Organization of Living Cells of Aspergillus fumigatus. Journal of Fungi. 6(2). 47–47. 24 indexed citations

Lackner, Michaela, Mike Birch, Nicola Beckmann, et al.. (2018). Dihydroorotate dehydrogenase inhibitor olorofim exhibits promising activity against all clinically relevant species within Aspergillus section Terrei. Journal of Antimicrobial Chemotherapy. 73(11). 3068–3073. 32 indexed citations

Wiederhold, Nathan P., Laura K. Najvar, Rosie Jaramillo, et al.. (2018). The Orotomide Olorofim Is Efficacious in an Experimental Model of Central Nervous System Coccidioidomycosis. Antimicrobial Agents and Chemotherapy. 62(9). 60 indexed citations

Pré, Saskia du, Nicola Beckmann, Graham E. M. Sibley, et al.. (2018). Effect of the Novel Antifungal Drug F901318 (Olorofim) on Growth and Viability of Aspergillus fumigatus. Antimicrobial Agents and Chemotherapy. 62(8). 80 indexed citations

10.

Wiederhold, Nathan P., Derek Law, & Michael Birch. (2017). Dihydroorotate dehydrogenase inhibitor F901318 has potent in vitro activity against Scedosporium species and Lomentospora prolificans. Journal of Antimicrobial Chemotherapy. 72(7). 1977–1980. 70 indexed citations

11.

Biswas, Chayanika, Derek Law, Michael Birch, et al.. (2017). In vitro activity of the novel antifungal compound F901318 against Australian Scedosporium and Lomentospora fungi. Medical Mycology. 56(8). 1050–1054. 60 indexed citations

12.

Hope, William, Laura McEntee, Joanne Livermore, et al.. (2017). Pharmacodynamics of the Orotomides against Aspergillus fumigatus : New Opportunities for Treatment of Multidrug-Resistant Fungal Disease. mBio. 8(4). 54 indexed citations

13.

Oliver, Jason D., Graham E. M. Sibley, Nicola Beckmann, et al.. (2016). F901318 represents a novel class of antifungal drug that inhibits dihydroorotate dehydrogenase. Proceedings of the National Academy of Sciences. 113(45). 12809–12814. 208 indexed citations

14.

Law, Derek. (2008). Pharmacokinetics of the Novel Antifungal Agent, FG3409 in Mouse. 46th Annual Meeting. 1 indexed citations

15.

Law, Derek. (2008). FG3409: A Novel Small Molecule Antifungal Agent with Activity against Aspergillus spp.. 46th Annual Meeting. 1 indexed citations

16.

Law, Derek. (2000). The history and evolution of Escherichia coli O157 and other Shiga toxin-producing E. coli. World Journal of Microbiology and Biotechnology. 16(8-9). 701–709. 13 indexed citations

17.

Moore, Caroline B., Derek Law, & David W. Denning. (1993). In-vitro activity of the new triazole D0870 compared with amphotericin B and itraconazole against Aspergilus spp.. Journal of Antimicrobial Chemotherapy. 32(6). 831–836. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact